SuperworthLucid Diagnostics shares outstanding LUCD
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Sep 30, 2025
- 108.2M
- On a year earlier
- +114.7%
- more shares
Lucid Diagnostics had 108.2M diluted shares outstanding on average in Q3 FY25, the quarter to Sep 30, 2025.
That is 114.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 58.4M | +38% |
| FY2023 | 42.3M | +13% |
| FY2022 | 37.4M | +17% |
| FY2021 | 31.9M | +126% |
| FY2020 | 14.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY25 | 108.2M | +115% | |
| Q2 FY25 | 99M | +105% | |
| Q1 FY25 | 68.8M | +53% | |
| Q4 FY24 | 58.4M | +38% | |
| Q3 FY24 | 50.4M | +20% | |
| Q2 FY24 | 48.2M | +15% | |
| Q1 FY24 | 45M | +10% | |
| Q4 FY23 | 42.3M | +13% | |
| Q3 FY23 | 41.9M | +15% | |
| Q2 FY23 | 41.8M | +17% | |
| Q1 FY23 | 41M | n/a | |
| Q4 FY22 | 37.4M | +17% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Lucid Diagnostics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.